The content outlines an enterprise taxonomy that includes four main categories: Medical Devices, Digital Health, Emerging Technologies, and Technology. Additionally, it mentions node settings to exclude this information from the Accelerate RSS feed.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
